Bipartisan Letter from Senators Opposing Part B Cuts
This week, 57 Senators signed a bipartisan letter to CMS urging the agency to reconsider its proposal to reduce Medicare Part B reimbursement for 340B drugs. The proposed rule would…
Upcoming House and Senate Hearings
The House Energy and Commerce (E&C) Committee will hold a hearing focused on the 340B program before the Oversight and Investigations Subcommittee on Wednesday, October 11 at 10 a.m. The hearing…
Mylan to Refund Covered Entities for EpiPen Overcharges
Mylan will refund 340B covered entities a total of $19.3 million for overcharges on the EpiPen as part of its recent settlement agreement with the Department of Justice resolving claims…
Recent GAO Report on 340B Program Oversight
The Government Accountability Office (GAO) submitted a report on 340B program oversight as part of its testimony during the House Energy and Commerce’s Subcommittee on Oversight and Investigations hearing on…
Draft Executive Order on Drug Prices
We received a copy of what we believe to be the Trump Administration’s draft executive order on drug prices that would direct HRSA to scale back the 340B Program. According…
Senate HELP to Hold Hearing on Drug Spending
The Senate Health, Education, Labor and Pensions (HELP) Committee will hold a hearing “in the near future” on drug spending. A bipartisan group of senators who serve on the HELP…
Johnson & Johnson to Issue 340B Overcharge Refunds
A notice from Johnson & Johnson (J&J) was posted on the HRSA website stating that J&J will be issuing refunds to covered entities for overcharges on certain drugs sold between…
GAO Reviewing 340B Contract Pharmacy Arrangements
The U.S. Government and Accountability Office (GAO) is examining 340B contract pharmacy arrangements, although we do not yet know the purpose of the GAO’s review. The GAO is the investigative…
Manufacturers Increase WAC Prices for HIV Medications
Several manufacturers of leading antiretroviral drugs increased wholesale acquisition cost (WAC) prices at the beginning of this year, despite an open letter submitted by the Fair Pricing Coalition and more…
Humana/Aetna Deal Off
Aetna and Humana announced today that they will terminate their merger agreement. Last month, a federal judge blocked the proposed transaction on the grounds that the purchase would violate federal…